Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan
Authors:
- Katsuhide KameiKKKatsuhide Kamei
- Noriko MaedaNMNoriko Maeda
- Kayoko NomuraKNKayoko Nomura
- Makoto ShibataMSMakoto Shibata
- Ryoko Katsuragi-OginoRKRyoko Katsuragi-Ogino
- Makoto KoyamaMKMakoto Koyama
- Mika NakajimaMNMika Nakajima
- Teruyoshi InoueTITeruyoshi Inoue
- Tomochika OhnoTOTomochika Ohno
- Toshio TatsuokaTTToshio Tatsuoka
- 1 March 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (6) , 1978-1992
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatments for strokeExpert Opinion on Emerging Drugs, 2003
- New 5-HT1A receptor agonists possessing 1,4-Benzoxazepine scaffold exhibit highly potent anti-ischemic effectsBioorganic & Medicinal Chemistry Letters, 2001
- Neuroprotective effect of 5-HT1A receptor agonist, Bay×3702, demonstrated in vitro and in vivoEuropean Journal of Pharmacology, 1998
- Role of hippocampal serotonergic neurons in ischemic neuronal deathBehavioural Brain Research, 1997
- MKC-242Drugs of the Future, 1997
- Regulation of glutamate release via NMDA and 5-HT1A receptors in guinea pig dentate gyrusBrain Research, 1996
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Neuropharmacology of anxiety: perspectives and prospectsTrends in Pharmacological Sciences, 1994
- Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemiaBrain Research, 1993
- Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats.Stroke, 1992